Видео ютуба по тегу Aml Idh1

The Practicalities of Personalised Therapy in IDH1-Mutated AML
The Practicalities of Personalised Therapy in IDH1-Mutated AML
Deep dive into targeted therapies: understanding IDH1-mutant AML treatments
Deep dive into targeted therapies: understanding IDH1-mutant AML treatments
Treatment strategies for patients with IDH1/2-mutated AML ineligible for intensive chemotherapy
Treatment strategies for patients with IDH1/2-mutated AML ineligible for intensive chemotherapy
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?
Clinical research round-up: Current and emerging treatments for IDH1-mutated AML
Clinical research round-up: Current and emerging treatments for IDH1-mutated AML
IDH1/2 Inhibitors for AML
IDH1/2 Inhibitors for AML
The prognostic value of IDH1 and IDH2 in acute myeloid leukemia (AML)
The prognostic value of IDH1 and IDH2 in acute myeloid leukemia (AML)
ICRN Webinar:
ICRN Webinar: "What is IDH1 mutated cholangiocarcinoma and what else can we do for it?”
Promising targets beyond FLT3 in AML: IDH1/2 & menin
Promising targets beyond FLT3 in AML: IDH1/2 & menin
Positive Results With Ivosidenib in IDH1-Mutated AML
Positive Results With Ivosidenib in IDH1-Mutated AML
How does pretransplant 𝘐𝘋𝘏1 and 𝘐𝘋𝘏2 MRD affect posttransplant outcomes in patients with AML?
How does pretransplant 𝘐𝘋𝘏1 and 𝘐𝘋𝘏2 MRD affect posttransplant outcomes in patients with AML?
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigation
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigation
AML: mutant IDH1 inhibitor HMS-101
AML: mutant IDH1 inhibitor HMS-101
IDH Mutations in Cancer
IDH Mutations in Cancer
The impact of IDH mutated clones in NPM1+ AML
The impact of IDH mutated clones in NPM1+ AML
AML On The Go: Targeted Therapy of IDH1/IDH2 Mutated AML
AML On The Go: Targeted Therapy of IDH1/IDH2 Mutated AML
Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations
Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations
Targeting IDH1/2 in AML
Targeting IDH1/2 in AML
Implications of Rapid IDH1/IDH2 Testing for Liquid and Solid Tumors
Implications of Rapid IDH1/IDH2 Testing for Liquid and Solid Tumors
IDH1/2 Inhibitors in AML
IDH1/2 Inhibitors in AML